Equitable and resilient health systems through regionalized vaccine manufacturing

The COVID-19 pandemic laid bare the weaknesses of a centralized vaccine manufacturing model, exposing its inability to meet the demands of an interconnected yet inequitable world. As countries struggled with supply chain disruptions, export restrictions, and delayed access to life-saving vaccines, the need for a fundamental shift became evident. The concept of regionalized vaccine manufacturing, explored in depth in the recent Lancet article, offers a transformative vision for addressing these challenges. It proposes a model that prioritizes equity, resilience, and alignment with regional health priorities, signaling a pivotal moment for global health systems. The centralized model, while successful in expanding routine immunization and reducing disease burdens over the decades, has inherent limitations. Its focus on global efficiencies often sidelines regional needs, particularly in low- and middle-income countries. The dependency on a few manufacturing hubs makes vaccine access vulnerable to geopolitical tensions and supply chain fragilities. This has prompted a growing recognition...